ResMed Operating Margin 2010-2024 | RMD

Current and historical operating margin for ResMed (RMD) over the last 10 years. The current operating profit margin for ResMed as of September 30, 2024 is 25.45%.
ResMed Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2024-09-30 $4.81B $1.42B 29.49%
2024-06-30 $4.69B $1.32B 28.18%
2024-03-31 $4.58B $1.21B 26.48%
2023-12-31 $4.50B $1.14B 25.31%
2023-09-30 $4.38B $1.15B 26.17%
2023-06-30 $4.22B $1.13B 26.81%
2023-03-31 $4.02B $1.11B 27.69%
2022-12-31 $3.76B $1.05B 27.76%
2022-09-30 $3.63B $1.01B 27.97%
2022-06-30 $3.58B $1.00B 27.94%
2022-03-31 $3.54B $0.99B 27.88%
2021-12-31 $3.44B $0.98B 28.34%
2021-09-30 $3.35B $0.95B 28.34%
2021-06-30 $3.20B $0.90B 28.28%
2021-03-31 $3.09B $0.89B 28.63%
2020-12-31 $3.09B $0.88B 28.47%
2020-09-30 $3.03B $0.86B 28.28%
2020-06-30 $2.96B $0.81B 27.40%
2020-03-31 $2.89B $0.71B 24.49%
2019-12-31 $2.78B $0.65B 23.24%
2019-09-30 $2.70B $0.61B 22.45%
2019-06-30 $2.61B $0.58B 22.22%
2019-03-31 $2.53B $0.61B 23.96%
2018-12-31 $2.46B $0.58B 23.79%
2018-09-30 $2.41B $0.57B 23.83%
2018-06-30 $2.34B $0.54B 23.15%
2018-03-31 $2.27B $0.52B 22.96%
2017-12-31 $2.20B $0.49B 22.45%
2017-09-30 $2.13B $0.44B 20.89%
2017-06-30 $2.07B $0.43B 20.57%
2017-03-31 $2.03B $0.42B 20.56%
2016-12-31 $1.97B $0.41B 21.04%
2016-09-30 $1.89B $0.43B 22.45%
2016-06-30 $1.84B $0.43B 23.32%
2016-03-31 $1.77B $0.41B 23.11%
2015-12-31 $1.74B $0.41B 23.65%
2015-09-30 $1.71B $0.41B 24.15%
2015-06-30 $1.68B $0.41B 24.43%
2015-03-31 $1.64B $0.41B 24.88%
2014-12-31 $1.62B $0.41B 25.19%
2014-09-30 $1.58B $0.40B 25.55%
2014-06-30 $1.56B $0.41B 26.05%
2014-03-31 $1.56B $0.39B 25.27%
2013-12-31 $1.54B $0.38B 24.92%
2013-09-30 $1.53B $0.37B 24.19%
2013-06-30 $1.52B $0.35B 23.35%
2013-03-31 $1.47B $0.36B 24.30%
2012-12-31 $1.44B $0.34B 23.57%
2012-09-30 $1.39B $0.31B 22.53%
2012-06-30 $1.37B $0.30B 21.55%
2012-03-31 $1.34B $0.27B 20.31%
2011-12-31 $1.30B $0.26B 19.88%
2011-09-30 $1.28B $0.26B 20.53%
2011-06-30 $1.24B $0.27B 21.48%
2011-03-31 $1.19B $0.27B 22.55%
2010-12-31 $1.16B $0.27B 22.95%
2010-09-30 $1.13B $0.25B 22.52%
2010-06-30 $1.09B $0.24B 22.05%
2010-03-31 $1.05B $0.23B 21.84%
2009-12-31 $1.00B $0.22B 22.16%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $35.199B $4.685B
ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $196.826B 25.11
Stryker (SYK) United States $146.166B 32.94
Boston Scientific (BSX) United States $145.408B 41.81
EssilorLuxottica (ESLOY) France $115.383B 0.00
Medtronic (MDT) Ireland $112.944B 16.78
Lonza Group Ag (LZAGY) Switzerland $43.849B 0.00
Haleon (HLN) United Kingdom $41.827B 27.18
GE HealthCare Technologies (GEHC) United States $38.715B 20.08
Terumo (TRUMY) Japan $27.980B 0.00
Koninklijke Philips (PHG) Netherlands $24.250B 18.56
Zimmer Biomet Holdings (ZBH) United States $21.811B 13.89
Insulet (PODD) United States $19.347B 77.04
Baxter (BAX) United States $15.818B 10.29
Smith & Nephew SNATS (SNN) United Kingdom $11.057B 0.00
Bio-Rad Laboratories (BIO) United States $9.586B 32.58
BellRing Brands (BRBR) United States $9.323B 37.51
Demant (WILYY) Denmark $8.735B 0.00
Lantheus Holdings (LNTH) United States $6.360B 14.78
ICU Medical (ICUI) United States $4.012B 38.20
Prestige Consumer Healthcare (PBH) United States $3.882B 19.31
Haemonetics (HAE) United States $3.691B 18.01
Envista Holdings (NVST) United States $3.413B 25.42
Perrigo (PRGO) Ireland $3.252B 9.57
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
QuidelOrtho (QDEL) United States $2.807B 18.07
GN Store Nord (GNNDY) Denmark $2.585B 16.58
Neogen (NEOG) United States $2.508B 28.90
LeMaitre Vascular (LMAT) United States $2.227B 54.13
AtriCure (ATRC) United States $1.876B 0.00
Green Thumb Industries (GTBIF) United States $1.572B 27.52
AdaptHealth (AHCO) United States $1.416B 10.11
InMode (INMD) Israel $1.410B 8.48
BioLife Solutions (BLFS) United States $1.213B 0.00
Maravai LifeSciences Holdings (MRVI) United States $1.205B 0.00
Owens & Minor (OMI) United States $1.124B 8.78
Curaleaf Holdings (CURLF) Canada $0.981B 0.00
Phibro Animal Health (PAHC) United States $0.843B 14.87
CeriBell (CBLL) United States $0.754B 0.00
Evolus (EOLS) United States $0.666B 0.00
Capricor Therapeutics (CAPR) United States $0.623B 0.00
VAREX IMAGING (VREX) United States $0.557B 24.58
Omeros (OMER) United States $0.541B 0.00
Surmodics (SRDX) United States $0.527B 0.00
Cresco Labs (CRLBF) United States $0.434B 0.00
Verano Holdings (VRNOF) United States $0.434B 0.00
ZimVie (ZIMV) United States $0.394B 33.23
Valneva SE (VALN) France $0.355B 0.00
Quanterix (QTRX) United States $0.342B 0.00
Cerus (CERS) United States $0.332B 0.00
Viemed Healthcare (VMD) United States $0.317B 30.18
Biote (BTMD) United States $0.306B 6.71
Sanara MedTech (SMTI) United States $0.285B 0.00
OraSure Technologies (OSUR) United States $0.272B 18.25
High Tide (HITI) Canada $0.250B 103.00
Zynex (ZYXI) United States $0.245B 51.20
Canopy Growth (CGC) Canada $0.237B 0.00
Sanuwave Health (SNWV) United States $0.226B 3.18
Aurora Cannabis (ACB) Canada $0.211B 0.00
Utah Medical Products (UTMD) United States $0.211B 14.56
Organigram Holdings (OGI) Canada $0.196B 0.00
Brainsway (BWAY) Israel $0.192B 102.30
MacroGenics (MGNX) United States $0.188B 0.00
TerrAscend (TSNDF) Canada $0.168B 0.00
TriSalus Life Sciences (TLSI) United States $0.150B 0.00
FitLife Brands (FTLF) United States $0.149B 18.77
Veru (VERU) United States $0.143B 0.00
Jin Medical (ZJYL) China $0.143B 0.00
Quipt Home Medical (QIPT) United States $0.130B 0.00
Fonar (FONR) United States $0.096B 10.87
Oramed Pharmaceuticals (ORMP) United States $0.092B 0.00
INLIF (INLF) $0.078B 0.00
InterCure (INCR) Israel $0.077B 0.00
Exagen (XGN) United States $0.070B 0.00
Rockwell Medical (RMTI) United States $0.069B 35.33
Jushi Holdings (JUSHF) United States $0.063B 0.00
Ayr Wellness (AYRWF) United States $0.058B 0.00
Cytosorbents (CTSO) United States $0.056B 0.00
Apyx Medical (APYX) United States $0.052B 0.00
ImmuCell (ICCC) United States $0.049B 0.00
Modular Medical (MODD) United States $0.042B 0.00
Safety Shot (SHOT) United States $0.033B 0.00
Nephros (NEPH) United States $0.017B 0.00
Innovative Eyewear (LUCY) United States $0.014B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Allurion Technologies (ALUR) United States $0.008B 0.00
Trinity Biotech (TRIB) Ireland $0.006B 0.00
Agape ATP (ATPC) $0.005B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Sharps Technology (STSS) United States $0.004B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 14.11
SNDL (SNDL) Canada $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00